bioA mutant of Mycobacterium tuberculosis shows severe growth defect and imparts protection against tuberculosis in guinea pigs. 2017

Ritika Kar, and Prachi Nangpal, and Shubhita Mathur, and Swati Singh, and Anil K Tyagi
Department of Biochemistry, University of Delhi South Campus, Benito Juarez Road, New Delhi, India.

Owing to the devastation caused by tuberculosis along with the unsatisfactory performance of the Bacillus Calmette-Guérin (BCG) vaccine, a more efficient vaccine than BCG is required for the global control of tuberculosis. A number of studies have demonstrated an essential role of biotin biosynthesis in the growth and survival of several microorganisms, including mycobacteria, through deletion of the genes involved in de novo biotin biosynthesis. In this study, we demonstrate that a bioA mutant of Mycobacterium tuberculosis (MtbΔbioA) is highly attenuated in the guinea pig model of tuberculosis when administered aerogenically as well as intradermally. Immunization with MtbΔbioA conferred significant protection in guinea pigs against an aerosol challenge with virulent M. tuberculosis, when compared with the unvaccinated animals. Booster immunization with MtbΔbioA offered no advantage over a single immunization. These experiments demonstrate the vaccinogenic potential of the attenuated M. tuberculosis bioA mutant against tuberculosis.

UI MeSH Term Description Entries
D009169 Mycobacterium tuberculosis A species of gram-positive, aerobic bacteria that produces TUBERCULOSIS in humans, other primates, CATTLE; DOGS; and some other animals which have contact with humans. Growth tends to be in serpentine, cordlike masses in which the bacilli show a parallel orientation. Mycobacterium tuberculosis H37Rv
D004195 Disease Models, Animal Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. Animal Disease Model,Animal Disease Models,Disease Model, Animal
D006168 Guinea Pigs A common name used for the genus Cavia. The most common species is Cavia porcellus which is the domesticated guinea pig used for pets and biomedical research. Cavia,Cavia porcellus,Guinea Pig,Pig, Guinea,Pigs, Guinea
D000637 Transaminases A subclass of enzymes of the transferase class that catalyze the transfer of an amino group from a donor (generally an amino acid) to an acceptor (generally a 2-keto acid). Most of these enzymes are pyridoxyl phosphate proteins. (Dorland, 28th ed) EC 2.6.1. Aminotransferase,Aminotransferases,Transaminase
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D001426 Bacterial Proteins Proteins found in any species of bacterium. Bacterial Gene Products,Bacterial Gene Proteins,Gene Products, Bacterial,Bacterial Gene Product,Bacterial Gene Protein,Bacterial Protein,Gene Product, Bacterial,Gene Protein, Bacterial,Gene Proteins, Bacterial,Protein, Bacterial,Proteins, Bacterial
D014376 Tuberculosis Any of the infectious diseases of man and other animals caused by species of MYCOBACTERIUM TUBERCULOSIS. Koch's Disease,Kochs Disease,Mycobacterium tuberculosis Infection,Infection, Mycobacterium tuberculosis,Infections, Mycobacterium tuberculosis,Koch Disease,Mycobacterium tuberculosis Infections,Tuberculoses
D032581 Tuberculosis Vaccines Vaccines or candidate vaccines used to prevent or treat TUBERCULOSIS. Tuberculosis Vaccine,Vaccine, Tuberculosis,Vaccines, Tuberculosis

Related Publications

Ritika Kar, and Prachi Nangpal, and Shubhita Mathur, and Swati Singh, and Anil K Tyagi
January 2018, Biology open,
Ritika Kar, and Prachi Nangpal, and Shubhita Mathur, and Swati Singh, and Anil K Tyagi
January 2013, PloS one,
Ritika Kar, and Prachi Nangpal, and Shubhita Mathur, and Swati Singh, and Anil K Tyagi
January 2022, PloS one,
Ritika Kar, and Prachi Nangpal, and Shubhita Mathur, and Swati Singh, and Anil K Tyagi
September 2017, The Journal of infectious diseases,
Ritika Kar, and Prachi Nangpal, and Shubhita Mathur, and Swati Singh, and Anil K Tyagi
October 2020, Scientific reports,
Ritika Kar, and Prachi Nangpal, and Shubhita Mathur, and Swati Singh, and Anil K Tyagi
June 2005, Vaccine,
Ritika Kar, and Prachi Nangpal, and Shubhita Mathur, and Swati Singh, and Anil K Tyagi
April 2021, Vaccines,
Ritika Kar, and Prachi Nangpal, and Shubhita Mathur, and Swati Singh, and Anil K Tyagi
January 2011, Antimicrobial agents and chemotherapy,
Ritika Kar, and Prachi Nangpal, and Shubhita Mathur, and Swati Singh, and Anil K Tyagi
March 2004, Infection and immunity,
Ritika Kar, and Prachi Nangpal, and Shubhita Mathur, and Swati Singh, and Anil K Tyagi
May 2004, Infection and immunity,
Copied contents to your clipboard!